Works matching AU Shem-Tov, Noga

Results: 16

Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation.

Published in:

2021

By:

Danylesko, Ivetta;
Sareli, Rina;
Varda-Bloom, Nira;
Yerushalmi, Ronit;
Shem-Tov, Noga;
Magen, Hila;
Shimoni, Avichai;
Nagler, Arnon

Publication type:

journal article

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

Published in:

American Journal of Hematology, 2017, v. 92, n. 10, p. 1011, doi. 10.1002/ajh.24827

By:

Shimoni, Avichai;
Vago, Luca;
Bernardi, Massimo;
Yerushalmi, Ronit;
Peccatori, Jacopo;
Greco, Raffaella;
Shem-Tov, Noga;
Lo Russo, Alessandro;
Danylesko, Ivetta;
Apel, Arie;
Bonini, Chiara;
Lupo Stanghellini, Maria Teresa;
Nagler, Arnon;
Ciceri, Fabio

Publication type:

Article

The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.

Published in:

American Journal of Hematology, 2017, v. 92, n. 3, p. 259, doi. 10.1002/ajh.24631

By:

Yerushalmi, Ronit;
Shem-Tov, Noga;
Danylesko, Ivetta;
Shouval, Roni;
Nagler, Arnon;
Shimoni, Avichai

Publication type:

Article

Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Published in:

Oncologist, 2015, v. 20, n. 1, p. 50, doi. 10.1634/theoncologist.2014-0187

By:

Shem‐Tov, Noga;
Labopin, Myriam;
Moukhtari, Leila;
Ciceri, Fabio;
Esteve, Jordi;
Giebel, Sebastian;
Gorin, Norbert‐Claude;
Schmid, Christopher;
Shimoni, Avichai;
Nagler, Arnon;
Mohty, Mohamad

Publication type:

Article

Fludarabine and treosulfan: A novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.

Published in:

Leukemia & Lymphoma, 2007, v. 48, n. 12, p. 2352, doi. 10.1080/10428190701671051

By:

Shimoni, Avichai;
Hardan, Izhar;
Shem-Tov, Noga;
Rand, Avital;
Yerushalmi, Ronit;
Nagler, Arnon

Publication type:

Article

P1400: THREE YEARS OUTCOMES OF PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS FOLLOWING ANTI CD19 CAR‐T CELL THERAPY ‐ A SINGLE CENTER EXPERIENCE.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972488.62933.fb

By:

Geva, Mika;
Fried, Shalev;
Itzhaki, Orit;
Shem‐Tov, Noga;
Danylesko, Ivetta;
Yerushalmi, Ronit;
Marcus, Ronit;
Sdayoor, Inbal;
Shapira‐Frommer, Ronnie;
Kedmi, Meirav;
Shouval, Roni;
Nagler, Arnon;
Shimoni, Avichai;
Avigdor, Abraham

Publication type:

Article

P889: POINT‐OF‐CARE ANTI‐BCMA CAR T‐CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH‐RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970460.94543.ab

By:

Magen, Hila;
Fried, Shalev;
Itzhaki, Orit;
Shem‐Tov, Noga;
Danylesko, Ivetta;
Yerushalmi, Ronit;
Shouval, Roni;
Marcus, Ronit;
Nevo, Lee;
Shapira‐Frommer, Ronnie;
Nagler, Arnon;
Shimoni, Avichai;
Shkury, Eden;
Abraham, Avigdor

Publication type:

Article

P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION.

Published in:

2023

By:

Danylesko, Ivetta;
Shem-Tov, Noga;
Yerushalmi, Ronit;
Jacoby, Elad;
Toren, Amos;
Itzhaki, Orit;
Shouval, Roni;
Shimoni, Avichai;
Abraham, Avigdor;
Nagler, Arnon

Publication type:

Abstract

Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 12, p. 1956, doi. 10.1080/10428194.2023.2246611

By:

Fried, Shalev;
Shkury, Eden;
Itzhaki, Orit;
Sdayoor, Inbal;
Yerushalmi, Ronit;
Shem-Tov, Noga;
Danylesko, Ivetta;
Jacoby, Elad;
Shouval, Roni;
Kedmi, Meirav;
Marcus, Ronit;
Nagler, Arnon;
Shimoni, Avichai;
Avigdor, Abraham

Publication type:

Article

Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 14, p. 3385, doi. 10.1080/10428194.2022.2123232

By:

Fried, Shalev;
Shouval, Roni;
Varda-Bloom, Nira;
Besser, Michal J.;
Yerushalmi, Ronit;
Shem-Tov, Noga;
Danylesko, Ivetta;
Jacoby, Elad;
Teihman, Shlomit;
Itzhaki, Orit;
Fein, Joshua A.;
Kedmi, Meirav;
Shimoni, Avichai;
Nagler, Arnon;
Avigdor, Abraham

Publication type:

Article

Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation.

Published in:

Annals of Hematology, 2015, v. 94, n. 3, p. 375, doi. 10.1007/s00277-014-2229-3

By:

Koren-Michowitz, Maya;
Maayan, Hannah;
Apel, Arie;
Shem-Tov, Noga;
Yerushalmi, Ronit;
Volchek, Yulia;
Avigdor, Abraham;
Shimoni, Avichai;
Nagler, Arnon

Publication type:

Article

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

Cancer (0008543X), 2015, v. 121, n. 6, p. 863, doi. 10.1002/cncr.29141

By:

Shimoni, Avichai;
Volchek, Yulia;
Koren‐Michowitz, Maya;
Varda‐Bloom, Nira;
Somech, Raz;
Shem‐Tov, Noga;
Yerushalmi, Ronit;
Nagler, Arnon

Publication type:

Article

Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Published in:

Acta Haematologica, 2021, v. 144, n. 6, p. 613, doi. 10.1159/000515902

By:

Danylesko, Ivetta;
Canaani, Jonathan;
Shimoni, Avichai;
Fein, Joshua;
Shem-Tov, Noga;
Yerushalmi, Ronit;
Shouval, Roni;
Nagler, Arnon

Publication type:

Article

Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study.

Published in:

Acta Haematologica, 2015, v. 135, n. 1, p. 29, doi. 10.1159/000435769

By:

Danylesko, Ivetta;
Sareli, Rina;
Varda-Bloom, Nira;
Yerushalmi, Ronit;
Shem-Tov, Noga;
Shimoni, Avichai;
Nagler, Arnon

Publication type:

Article

Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients.

Published in:

British Journal of Haematology, 2022, v. 196, n. 4, p. 884, doi. 10.1111/bjh.17918

By:

Shem‐Tov, Noga;
Yerushalmi, Ronit;
Danylesko, Ivetta;
Litachevsky, Vladislav;
Levy, Itzchak;
Olmer, Liraz;
Lusitg, Yaniv;
Avigdor, Abraham;
Nagler, Arnon;
Shimoni, Avichai;
Rahav, Galia

Publication type:

Article

Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.

Published in:

European Journal of Haematology, 2019, v. 103, n. 4, p. 402, doi. 10.1111/ejh.13299

By:

Shouval, Roni;
Kouniavski, Elizaveta;
Fein, Joshua;
Danylesko, Ivetta;
Shem‐Tov, Noga;
Geva, Mika;
Yerushalmi, Ronit;
Shimoni, Avichai;
Nagler, Arnon

Publication type:

Article